Denver, CO., May 15, 2018 (GLOBE NEWSWIRE) -- Ubiquitech Software Corp. (OTC: UBQU), through its operating subsidiary HempLifeToday.com, is expanding its position in the multi-billion Dollar skin care market, and entering the lucrative sports medicine market, with two new CannazALL™ Hemp CBD products currently under development.
The new CannazALL Hemp CBD products are a 4oz 200mg CBD Skin Lotion, and a 2oz 150mg CBD muscle Gel. Both are uniquely infused with essential oils, botanicals, vitamins, as well as pleasing organic scents. These new products will be sold alongside the Companies very popular CannazALL™ CBD Skin Salve, giving the Company a strong position in the skin care and sports medicine CBD market.
The New CannazALL products will feature a price point similar to the Company’s popular Skin Salve, and the Company will also offer a “Bundled” offer, of its new Skin Lotion, Muscle Gel, and Skin Salve at a special price.
CEO James Ballas stated “With the addition of these new products we are gaining yet another entre into the expanding CBD marketplace, and this gives us additional avenues to reach more customers. The new skin lotion and muscle gel are highly sought after and we have great plans for these products”
COO Luke Dreyer added “We are constantly striving to create the best business in our space and we continue to position for growth. We believe that we are very close to a huge growth period as we have taken the time to create a large footprint in the industry, and to build a first class reputation as well. It takes time to develop what we have and we are very close to seeing the results of our efforts”
These new CannazALL™ CBD products will be available on the HempLifeToday.com Website by June 30th and the Company will be announcing additional products in the coming weeks.
James Ballas adds “Everything we do is based on our desire to grow the Company in a manner that ensures smooth operations and compliance with our industry. As Luke mentioned, we absolutely believe we are close to the rapid growth we have been pursuing and that is great for our customers, the Company, and our shareholders”
HempLife Today™ is expecting to continue to capitalize on the surging Cannabis market that many are projecting to reach 18 billion per year by 2021. With a strong percentage of this contributed to hemp based products the Company expects to continue its growth by offering quality CannazALL™ hemp derived CBD, and full spectrum hemp products, to the public.
The Company has initiated additional shareholders services and many shareholders have already reached out to Craig Fischer for corporate updates. The company intends to update on additional new product offerings throughout the summer, and will also have news on its new division called CryptoBuy™ in the near future.
About Ubiquitech Software Corp
Ubiquitech Software Corp, through its subsidiaries is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, DirectResponse (DRTV) Television, Radio, Internet Content, and traditional marketing to drive traffic to the new and emerging multi-billion dollar industries like its subsidiaries HempLifeToday™ and CryptoBuy.com
About HempLife Today™
HempLifeToday™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers HempLifeToday.com™ has developed multiple and proprietary CannazALL™ CBD oil products that include; It’s popular CBD Tinctures, Concentrated Oils, GelCaps, Skin Salve, e-liquid, and CannazALL Pets™ CBD products all offered @ www.HempLifeToday.com
About CryptoBuy
CryptoBuy.com focuses on the burgeoning new world of Crypto Currencies and is created to be a service to persons interested in tracking and trading the many existing and future Crypto Currencies worldwide.
This press release contains forward-looking statements. Words such as "expects", "intends'', "believes'', and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company's filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward- looking statements in order to reflect events or circumstances that may arise after the after the date of this release.